There are 383 resources available
How MRD correlates with imaging in NSCLC?
Presenter: Francesco Grossi
Session: Minimal residual disease, biological disease
Resources:
Slides
Webcast
MRD as a predictor of survival in NSCLC
Presenter: Paul Hofman
Session: Minimal residual disease, biological disease
Resources:
Slides
Webcast
How to design clinical trials integrating MRD?
Presenter: Shirish Gadgeel
Session: Minimal residual disease, biological disease
Resources:
Slides
Webcast
Q&A
Session: Minimal residual disease, biological disease
Resources:
Webcast
Biomarker testing (tissue, blood) for non-oncogenic addicted NSCLC
Presenter: Thomas Stinchcombe
Session: First line in non-oncogene addicted
Resources:
Slides
Webcast
First line therapy in non-oncogene addicted NSCLC
Presenter: Maurice Perol
Session: First line in non-oncogene addicted
Resources:
Slides
Webcast
Resistance to therapy in non-oncogene addicted NSCLC
Presenter: Solange Peters
Session: First line in non-oncogene addicted
Resources:
Slides
Webcast
Long term needs and survivorship needs in advanced NSCLC
Presenter: Josephine Feliciano
Session: First line in non-oncogene addicted
Resources:
Slides
Webcast
Q&A
Session: First line in non-oncogene addicted
Resources:
Webcast
Invited Discussant of 1O
Presenter: Christine Lovly
Session: Proffered Paper session
Resources:
Slides
Webcast